VRDN
USDViridian Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$22.720
Máximo
$23.050
Mínimo
$22.140
Volumen
4.98M
Fundamentos de la Empresa
Capitalización de Mercado
2.1B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
1.03M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target
BTIG analyst Julian Harrison reiterates Viridian Therapeutics with a Buy and maintains $61 price target.
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug's Breakthrough Therapy Designation supports
Acciones Relacionadas
SLGN
Silgan Holdings Inc.
LTRYW
Lottery.com Inc. Warrants
ASXC
Asensus Surgical Inc.
SOHON
Sotherly Hotels Inc. 8.25% Series D Cumulative Redeemable Perpetual Preferred Stock
MPWR
Monolithic Power Systems Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.